Sentence examples for conclusions of safety from inspiring English sources

It was arguably justified to conduct some animal experimentation to confirm the conclusions of safety based on analytical chemistry, particularly in the early years when analytical techniques were less sophisticated than current techniques.

We show below that there is now overwhelming evidence demonstrating that these different experimental approaches lead to very different conclusions of safety with regard to the current reference dose for BPA of 50 μg/kg/day.

Much higher levels have been tested without adverse effects and may be safe, but the data for intakes above 1200 mg/day are not sufficient for a confident conclusion of safety.

Despite the impressive advances in the world of virtual biology, the anatomic, physiologic, and pharmacologic complexities of the entwined maternal-placental-fetal unit as well as the varied potential mechanisms for compensation in reaction to challenges are not yet able to be sufficiently well-modeled to enable a conclusion of safety.

"The regulators tend to use the company data rather than independent sources, and the company data we have found to be inappropriately rigged to force the conclusion of safety".

Even if the conclusion of safety was obtained in early exploratory studies, the verification study must also carefully evaluate safety through the monitoring of appropriate subjects.

An observational study of patients with head trauma demonstrated that a higher N intake provided a better short-term N balance, which at best supports the conclusion of safety [ 115].

Only larger studies with longer exposure times in special patient populations (ICU) could demonstrate possible benefits of the surface coating in reduction of VAP and produce experience supporting extrapolation of conclusion on safety from this limited study into general patient population.

Due to this immaturity, the MAP3 trial does not allow for any conclusion of the safety and long-term efficacy of this drug.

45 However, after conclusion of the safety review of sibutramine, the European Medicines Agency has suspended its marketing authorisation in the European Union (EU).

However, due to the limited number of cases included in this study, more studies may be required to substantiate the results and arrive at a definite conclusion, in terms of safety and efficacy of adding on antioxidant therapy for the treatment of RA.